Eli Lilly Targets Asian Cialis Market
(PRLEAP.COM) Lilly ICOS, a joint venture of Indianapolis-based Eli Lilly & Co. and ICOS Corp. of Bothell, Washington manufactures its own anti-impotence drug - Cialis that works by inhibiting PD5. (more…)
(PRLEAP.COM) Lilly ICOS, a joint venture of Indianapolis-based Eli Lilly & Co. and ICOS Corp. of Bothell, Washington manufactures its own anti-impotence drug - Cialis that works by inhibiting PD5. (more…)
The Food and Drug Administration (FDA) today approved a new vaccine for a single booster immunization against pertussis (whooping cough), in combination with tetanus and diphtheria, for adolescents and adults 11-64 years of age. (more…)
The Food and Drug Administration (FDA) is taking action to ensure that the public is fully aware that Able Laboratories of Cranbury, NJ, is conducting a nationwide recall of all of its manufactured drugs (mostly generic prescription drugs, including drugs containing acetaminophen) because of serious concerns that they were not produced according to quality assurance standards. Able Laboratories has ceased all current production. (more…)
Rockville, MD — Working in collaboration with the private sector and with other government agencies over the past year, the Food and Drug Administration (FDA) is announcing significant progress in the battle against counterfeit prescription drugs. In its annual update to the “Combating Counterfeit Drugs” Report, the FDA reports it is pursuing several initiatives to further protect the safety and integrity of the U.S. drug supply. (more…)
The Food and Drug Administration (FDA) is warning the public about the sale of counterfeit versions of Lipitor, Viagra, and an unapproved product promoted as “generic Evista” to U.S. consumers at pharmacies in Mexican border towns. (more…)
The Food and Drug Administration (FDA) today approved the first combination vaccine that provides a booster immunization against pertussis (whooping cough) in combination with tetanus and diphtheria for adolescents. The vaccine will be marketed as Boostrix by GlaxoSmithKline (GSK) in Philadelphia, Pa. (more…)
FDA is requiring that a new Bolded Warning be added to the labeling for Gabitril (tiagabine) an antiepileptic drug that’s approved as adjunctive therapy in treating partial seizures. The warning is being issued because of reports that Gabitril has been associated with seizures in more than 30 patients who received it for conditions other than epilepsy. (more…)
FDA recently provided health care practitioners and patients with updated information about the risks and benefits of Crestor (rosuvastatin calcium), a cholesterol-lowering drug made by Astra-Zeneca Pharmaceuticals. (more…)
Fort Lee, New Jersey…May 5, 2005…Alpharma Inc. (NYSE:ALO), a leading global generic pharmaceutical company, today announced that it has been notified by United States Food and Drug Administration that its pending application for Kadian® 200mg capsule has received approvable status. (more…)
FDA recently approved a new injectable drug to help control blood sugar in adult patients with Type 1 and Type 2 diabetes. It’s called Symlin, or pramlintide acetate, and it’s manufactured by Amylin Pharmaceuticals. (more…)